improve:Interestingly, compared with fibrosis, the proportion of NK cells in the blood…
- User
improve:Interestingly, compared with fibrosis, the proportion of NK cells in the blood of fibrosis mice receiving IL-10 intervention decreased, and the proportion of peripheral NK cells (CNK) characterized by (cd49a-cd49b+) in the liver increased, while the proportion of liver resident NK cells (lrnk) characterized by (cd49a+cd49b-) decreased
- Assistant
Interestingly, our observations revealed intriguing differences in the distribution of NK cells in fibrosis mice receiving IL-10 intervention. Specifically, we found a reduced proportion of NK cells in the bloodstream, contrasting with an increased proportion of peripheral NK cells (CNK) characterized by the expression of CD49a and CD49b in the liver. On the other hand, there was a noticeable decline in the proportion of liver resident NK cells (lrnk) identified by the lack of CD49b expression but retaining CD49a expression.
- User
improve:After IL-10 treatment in fibrotic mice, the number of NK cells in the liver with strong cytotoxicity and cytokine secretion ability significantly increased
- Assistant
After administering IL-10 treatment to fibrotic mice, we made an intriguing observation - there was a notable increase in the population of NK cells within the liver. These NK cells exhibited heightened cytotoxicity and demonstrated enhanced secretion of cytokines, suggesting their potent immunological capabilities. This finding highlights the potential therapeutic effect of IL-10 in boosting the immune response mediated by NK cells, specifically within the liver microenvironment of fibrotic mice.
- User
Modify and check:Previous studies have demonstrated that intervention with IL-10 effectively enhances the quantity and functionality of NK cells in liver tissue. The level of NK cell maturity is closely linked to their functionality, with three distinct developmental stages: immature (cd27+cd11b-), developing (cd27+cd11b+), and mature (cd27-cd11b+). Following IL-10 treatment in fibrotic mice, there was a substantial increase in the population of developing NK cells within the liver that displayed enhanced cytotoxicity and cytokine secretion capabilities. Intriguingly, the administration of IL-10 intervention in fibrotic mice led to a notable decrease in the proportion of NK cells in the bloodstream. Upon further examination of liver NK cell subpopulations, it was it was found that the proportion of peripheral NK cells (CNK) characterized by (cd49a-cd49b+) significantly increased, while the proportion of liver resident NK cells (lrnk) characterized by (cd49a+cd49b-) decreased.
- Assistant
Previous studies have demonstrated that intervention with IL-10 effectively enhances both the quantity and functionality of NK cells in liver tissue. In particular, the level of NK cell maturity has been identified as a crucial factor determining their functionality, with three distinct developmental stages: immature (cd27+cd11b-), developing (cd27+cd11b+), and mature (cd27-cd11b+). Remarkably, following IL-10 treatment in fibrotic mice, there was a significant increase in the population of developing NK cells within the liver, which exhibited enhanced cytotoxicity and cytokine secretion capabilities.
Intriguingly, the administration of IL-10 intervention in fibrotic mice resulted in a noteworthy decrease in the proportion of NK cells circulating in the bloodstream. Further analysis of liver NK cell subpopulations revealed a distinctive change in distribution. Specifically, there was a substantial increase in the proportion of peripheral NK cells (CNK) characterized by the expression of cd49a and cd49b-, while the proportion of liver resident NK cells (lrnk) characterized by the expression of cd49a+cd49b- exhibited a marked decrease.
These findings shed light on the complex alterations that occur within the NK cell compartment in response to IL-10 treatment in fibrotic mice. They suggest a potential role for IL-10 in modulating NK cell distribution and functionality, ultimately contributing to the regulation of the immune response in the liver microenvironment during fibrosis.
- User
improve:Previous studies have provided compelling evidence indicating that IL-10 intervention effectively enhances both the quantity and functionality of NK cells within liver tissue. It is worth noting that the functionality of NK cells is closely associated with their maturity levels, which can be classified into three distinct stages: immature (cd27+cd11b-), developing (cd27+cd11b+), and mature (cd27-cd11b+). In the context of fibrotic mice receiving IL-10 treatment, a significant increase was observed in the population of developing NK cells within the liver. These developing NK cells exhibited remarkable cytotoxicity and cytokine secretion capabilities, indicating the beneficial effects of IL-10 intervention on NK cell functionality. Intriguingly, the administration of IL-10 intervention in fibrotic mice resulted in a notable reduction in the proportion of NK cells within the bloodstream. Further analysis of liver NK cell subpopulations revealed that the proportion of peripheral classic NK cells (cNK) characterized by the surface markers (cd49a-cd49b+) exhibited a substantial increase. Conversely, there was a significant decrease in the proportion of liver resident NK cells (lrnk) identified by the surface markers (cd49a+cd49b-). Additionally, among various chemokines present in the liver, including CCL2, CCL3, and CCL5, it was observed that only CCL5, a chemokine known for its distinct ability to attract NK cells, showed a significant increase in the IL-10 group, highlighting its potential role in the observed increase of NK cell presence in the liver following IL-10 intervention.These findings suggest a potential role for IL-10 in modulating NK cell distribution and functionality, ultimately contributing to the regulation of the immune response in the liver microenvironment during fibrosis.
- Assistant
Previous studies have convincingly demonstrated that IL-10 intervention effectively enhances both the quantity and functionality of NK cells within liver tissue. Notably, the functionality of NK cells is closely tied to their maturity levels, which can be categorized into three distinct stages: immature (cd27+cd11b-), developing (cd27+cd11b+), and mature (cd27-cd11b+). Fascinatingly, in the context of fibrotic mice receiving IL-10 treatment, there was a substantial augmentation observed in the population of developing NK cells within the liver. These developing NK cells exhibited remarkable cytotoxicity and demonstrated impressive abilities in cytokine secretion, underscoring the beneficial effects of IL-10 intervention on the functionality of NK cells.
Adding to the intrigue, the administration of IL-10 intervention in fibrotic mice resulted in a noteworthy reduction in the proportion of NK cells within the bloodstream. Further analysis of liver NK cell subpopulations unveiled significant changes in their distribution. Specifically, there was a marked increase in the proportion of peripheral classic NK cells (cNK) characterized by the expression of surface markers (cd49a-cd49b+). In contrast, there was a noticeable decrease in the proportion of liver resident NK cells (lrnk) identified by the surface marker expression (cd49a+cd49b-). Moreover, among the various chemokines present in the liver, including CCL2, CCL3, and CCL5, it was intriguing to observe that only CCL5, a chemokine known for its distinct ability to attract NK cells, exhibited a significant increase in the IL-10 group. This highlights the potential role of CCL5 in facilitating the observed increase in NK cell presence within the liver following IL-10 intervention.
Taken together, these findings suggest a potential role for IL-10 in modulating both the distribution and functionality of NK cells, ultimately contributing to the regulation of the immune response within the liver microenvironment during fibrosis.
- User
Summarize this paragraph in short sentences:Previous studies have provided compelling evidence indicating that IL-10 intervention effectively enhances both the quantity and functionality of NK cells within the liver tissue. It is noteworthy that the functionality of NK cells is closely associated with their maturity levels, which can be classified into three distinct stages: immature (cd27+cd11b-), developing (cd27+cd11b+), and mature (cd27-cd11b+). In the context of fibrotic mice receiving IL-10 treatment, a significant increase was observed in the population of developing NK cells within the liver. These developing NK cells exhibited remarkable cytotoxicity and cytokine secretion capabilities, indicating the beneficial effects of IL-10 intervention on NK cell functionality. Interestingly, the administration of IL-10 intervention in fibrotic mice resulted in a notable reduction in the proportion of NK cells circulating in the bloodstream. Further analysis of liver NK cell subpopulations revealed that the proportion of peripheral classic NK cells (cNK) characterized by the surface markers (cd49a-cd49b+) exhibited a substantial increase. Conversely, there was a significant decrease in the proportion of liver resident NK cells (lrnk) identified by the surface markers (cd49a+cd49b-). Moreover, among several chemokines detected in the liver, including CCL2, CCL3, and CCL5, it was observed that only CCL5, a chemokine known for its specific ability to attract NK cells, showed a significant increase in the IL-10 group, emphasizing its potential role in the observed increase in NK cell presence in the liver following IL-10 intervention. These findings collectively suggest a crucial role for IL-10 in modulating both the distribution and functionality of NK cells, ultimately contributing to the regulation of the immune response within the liver microenvironment during fibrosis. Further investigation is warranted to fully elucidate the underlying mechanisms and potential therapeutic applications of IL-10 in the context of liver fibrosis.
- Assistant
IL-10 intervention enhances quantity and functionality of NK cells in the liver. Developing NK cells increase with IL-10 treatment, exhibiting cytotoxicity and cytokine secretion. IL-10 leads to decreased NK cell proportion in the bloodstream but increased proportion of peripheral classic NK cells in the liver. Liver resident NK cells decrease. CCL5, a chemokine attracting NK cells, increases with IL-10. IL-10 modulates NK cell distribution and functionality in liver fibrosis. Further research is needed for understanding and therapeutic potential.
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.